Can I taper trazodone to 12.5 mg while initiating another sleep medication simultaneously?

Tapering Trazodone While Starting Another Sleep Medication

Yes, you can taper trazodone to 12.5 mg while simultaneously starting another sleep medication, but you should ideally discontinue trazodone entirely rather than maintain such a low dose, as trazodone is not recommended for insomnia treatment according to current guidelines.

Key Recommendation Based on Guidelines

The American Academy of Sleep Medicine (2017) explicitly recommends against using trazodone for sleep onset or sleep maintenance insomnia 1. This is a critical starting point—if you're using trazodone primarily for sleep (not depression), you should be transitioning away from it entirely, not maintaining even a low dose.

Practical Approach to Transitioning

Tapering Strategy

Gradual dose reduction is recommended to avoid withdrawal symptoms, which can include anxiety, agitation, and sleep problems 2. The FDA label specifically advises to "gradually reduce the dosage rather than stopping Trazodone Hydrochloride Tablets abruptly whenever possible" 2.

• 12.5 mg is an extremely low dose (typical therapeutic doses for depression are 150-600 mg/day 2)
• At this low dose, you're likely experiencing minimal pharmacologic effect
• Consider discontinuing entirely rather than maintaining 12.5 mg long-term

Simultaneous Initiation of New Sleep Medication

You can start a new sleep medication while tapering trazodone, but the choice of new medication matters significantly:

Guideline-recommended options for insomnia include 1:

• Suvorexant (orexin receptor antagonist) for sleep maintenance
• Eszopiclone (2-3 mg) for sleep onset and maintenance
• Zolpidem (10 mg) for sleep onset and maintenance
• Doxepin (3-6 mg) for sleep maintenance insomnia
• Zaleplon (10 mg) for sleep onset only
• Ramelteon (8 mg) for sleep onset

Important Safety Considerations

Drug interactions and overlap concerns:

1. Avoid combining with other serotonergic agents during the taper to prevent serotonin syndrome 2. If your new sleep medication is an antidepressant with serotonergic properties, coordinate carefully with your prescriber.

2. Additive sedation risk: Trazodone causes significant drowsiness 2, 3. When overlapping with another sedating medication, monitor for:

   • Excessive daytime sedation
   • Impaired coordination
   • Risk of falls (especially in older adults)
   • Cognitive impairment

3. Cardiac considerations: Trazodone can cause QT prolongation and orthostatic hypotension 2. Ensure your new medication doesn't compound these risks.

Why Trazodone Shouldn't Be Your Long-Term Sleep Solution

The evidence against trazodone for insomnia is substantial:

• Weak evidence base: The AASM guideline recommendation against trazodone is based on low-quality evidence showing benefits approximately equal to harms 1
• Adverse effects outweigh benefits: Recent meta-analyses show trazodone increases adverse effects (RR = 1.18), sleep-related adverse effects (RR = 4.31), and dropouts due to side effects (RR = 2.30) 3
• Limited objective benefit: While trazodone may improve subjective sleep quality, it doesn't significantly affect perceived total sleep time 3
• Better alternatives exist: Multiple FDA-approved medications have stronger evidence for insomnia treatment 1

Practical Timeline

Week 1-2: Start new sleep medication at recommended dose while maintaining current trazodone dose (if higher than 12.5 mg, taper to 12.5 mg)

Week 2-3: If new medication is effective and well-tolerated, discontinue trazodone entirely

Monitor for: Rebound insomnia, withdrawal symptoms (anxiety, agitation), or inadequate sleep control with new medication alone

Common Pitfalls to Avoid

1. Don't maintain trazodone indefinitely at low doses "just in case"—this exposes you to ongoing risks without clear benefit
2. Don't abruptly stop if you've been on higher doses—taper gradually per FDA guidance 2
3. Don't combine with multiple sedating medications long-term—polypharmacy increases fall risk and cognitive impairment
4. Don't use trazodone as first-line for insomnia—it lacks the evidence base of approved alternatives 1, 4

Your plan to taper to 12.5 mg while starting another medication is reasonable as a transitional strategy, but aim for complete discontinuation of trazodone within 2-4 weeks if the new medication proves effective.